• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

H Lundbeck A/S

+ Add to Watchlist


16.707 EUR 0.125 0.74%

As of 11:19:26 ET on 07/11/2014.

Snapshot for H Lundbeck A/S (LDB)

Open: 16.615 Day's Range: 16.615 - 17.100 Volume: 0
Previous Close: 16.832 52wk Range: 14.390 - 23.390 1-Yr Rtn: +14.61%

Stock Chart for LDB

No chart data available.
  • LDB:GR 16.707
  • 1D
  • 1M
  • 1Y
Interactive LDB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LDB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 48.4470
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 2.5710
Est. PEG Ratio -
Market Cap (M EUR) 3,280.90
Shares Outstanding (M) 196.38
30 Day Average Volume 127
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.22%
Cash Dividend (DKK) 2.7700
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 3.74%
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LDB

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for LDB

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Thorleif KrarupDeputy ChairmanUlf WiinbergPresident/CEO
Anders GotzscheExec VP/CFOAnders Gersel PedersenExec VP:Research & Dev
More Company Profile & Key Executives for LDB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil